Pamela Kaufman: Anti-Obesity Meds Could Bite Into Food Sales

This podcast episode examines the impact of anti-obesity medications, specifically GLP-1 drugs, on food spending and consumption patterns. GLP-1 drugs reduce appetite and alter food preferences, leading to significant changes in consumption patterns and spending habits. The growing use of GLP-1 drugs is projected to have a substantial impact on various food and beverage industries, including fast food chains and casual restaurants.